Home
Scholarly Works
AIDA STEMI: no benefit for intracoronary abciximab
Journal article
AIDA STEMI: no benefit for intracoronary abciximab
Authors
Bertrand OF; Jolly S
Journal
The Lancet, Vol. 379, No. 9819, pp. 875–877
Publisher
Elsevier
Publication Date
January 1, 2012
DOI
10.1016/s0140-6736(12)60079-8
ISSN
0140-6736
Associated Experts
Sanjit Jolly
Professor, FHSMED
Visit profile
Labels
Fields of Research (FoR)
32 Biomedical and clinical sciences
42 Health sciences
Medical Subject Headings (MeSH)
Abciximab
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal
Female
Humans
Immunoglobulin Fab Fragments
Male
Myocardial Infarction
Platelet Aggregation Inhibitors
View published work (Non-McMaster Users)
View published work (McMaster Users)
Scholarly citations from Dimensions
Contact the Experts team
Get technical help
or
Provide website feedback